|Day Low/High||208.40 / 211.84|
|52 Wk Low/High||151.74 / 226.44|
Who, out there in the health care sector, is safe?
Jim discusses GE, Comcast, Illinois Tool Works, and Abbott Labs, all of which reported earnings Wednesday morning.
In today's video, Jim discusses the government shutdown, an Eli Lilly downgrade, Schlumberger after Friday's earnings, and several other market-related topics.
It's hard to understand the magnitude of the change.
The most recent short interest data has been released for the 12/29/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
In today's video, Jim discusses our newest initiation in Constellation Brands, Danaher at the JP Morgan Healthcare conference, and energy stocks.
You can make a case to buy any of the stocks of the companies at ICR.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Thermo Fisher Scientific Inc has taken over the #14 spot from Salesforce. om Inc , according to ETF Channel.
These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.
Moving into higher-margin products could boost Amazon's gross margins by 1,000 basis points, one analyst contends.
It looks like China is building again.
All the great stocks have artificial intelligence and e-commerce in common.
Cryo-electron microscopes are used to "see the molecules inside the cell and how they interact"
Kymriah™ (tisagenlecleucel, formerly CTL019), the first FDA-approved CAR-T cell therapy, uses CTS Dynabeads CD3/CD28 spherical beads to isolate, activate and expand T cells
Tender Offer Scheduled to Expire at 5:00 p.m., New York City Time, on August 28, 2017
What's next for shares of Agilent Technology.
Cramer examines how the secondaries are getting some primary attention and also observes that the market is becoming more discerning.
Thermo Fisher and McCormick deals show the true colors of stocks.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.